Transfection Reagents and Equipment Market Size, Share, Growth, and Industry Analysis, By Type (Biochemical, Physical, Viral and Others), By Application (Biomedical, Protein Production and Others), Regional Insights and Forecast From 2025 To 2033

• 

  Request a Free sample to learn more about this report

TRANSFECTION REAGENTS AND EQUIPMENT MARKET OVERVIEW

The global transfection reagents and equipment market size, valued at USD 0.82 billion in 2024, is expected to climb to USD 1.22 billion by 2033 at a CAGR of 4.2% during the forecast period.

Transfection is the act of inserting genetic material (such as DNA or RNA) into eukaryotic cells to allow the cell's own mechanism to create proteins. Double-stranded RNA transfection is used to prevent the creation of specific proteins by interfering with the translation process. The transfection technique allows researchers to investigate gene function and expression, gene mutation, and protein function. The transfection procedure is separated into two stages: stable transfection and transient transfection. Transfection reagents with unique membrane active properties help the transfection complex enter the plasma and endocytic membranes in the cell.

COVID-19 IMPACT

Pandemic hampered the market due to unexpected disruption in the sector

The global COVID-19 pandemic has been unprecedented and staggering, with the market experiencing lower-than-anticipated demand across all regions compared to pre-pandemic levels.  The sudden spike in CAGR is attributable to demand returning to pre-pandemic levels once the pandemic is over.

Many companies working on COVID-19 vaccines used viral vectors to achieve effective vaccination delivery. However, the manufacture of viral vectors was a time-consuming and difficult procedure, and any improvements to that process could result in more vaccinations being available faster. The viral vector-producing cells must be transfected with several plasmids containing various viral genes as well as the vaccination. During the initial pandemic, transfection reagents and equipment were increasingly used in the production and research of vaccinations. As a result, the pandemic had a substantial impact on market growth; however, now that the pandemic has receded, the analysed market is predicted to have stable growth during the study's forecast period.

LATEST TRENDS

The Product Launches and the Technological Advancements to Expand the Market Share

The market for transfection reagents and equipment is anticipated to grow as a result of rising R&D activities by pharmaceutical and biotechnology companies to develop advanced healthcare technology, an increase in the use of novel biotechnology techniques, an increase in construction costs for such facilities, ongoing advancements in the field of cancer research to create efficient cancer treatment methods, and strategic moves by important market players.

For instance, Polyplus Transfection SA announced the release of the first PEIpro transfection reagent that complies with GMP standards in 2020. This reagent is intended for use in the manufacture of cell and gene therapies using lentivirus and adeno-associated viruses in preclinical, clinical, and commercial settings. A novel, high-quality transfection reagent called TransIT-Virusgen Select was launched in 2019 by Mirus Bio. Large-scale viral generation with this reagent is intended for preclinical and clinical phase investigations.

Request a Free sample to learn more about this report

TRANSFECTION REAGENTS AND EQUIPMENT MARKET SEGMENTATION

By Type

Based on type: the transfection reagents and equipment market is divided into biochemical, physical, viral, and others.

The part biochemical is the leading part of the type segment.

By Application

Based on the application: the transfection reagents and equipment market is divided into biomedical, protein production, and others.

The part biomedical is the leading part of the application segment.

DRIVING FACTORS

The Rising Prevalence of Chronic Diseases to Uplift the Market Demand

Worldwide, the incidence of chronic diseases is rising, increasing the need for precise and efficient medical care. Targeted modified genes are delivered via transfection reagents and equipment to cure a variety of hereditary disorders. Additionally, the CRISPR gene, which can improve adaptive immunity and shield a person from many diseases, is delivered through the transfection technique.

The rising prevalence of infectious diseases like COVID-19 and other chronic diseases has sparked the development of efficient gene therapy devices that can replace the wrong gene with the right one. Gene therapy is one application of the transfection technique that is very common. Gene therapy and transfection techniques are becoming more popular as the need for precise and effective medical care grows globally. Additionally, numerous ongoing studies showing that gene therapy has the potential to treat chronic diseases are raising demand for it among doctors and patients. This indicates that the expansion of the global transfection Reagent and equipment market is being driven by the rising prevalence of chronic diseases.

Development of Synthetic Biology Products to Drive the Market Growth

A new age of biology called synthetic biology applies engineering principles to biology. In synthetic biology, DNA is chemically created by reassembling DNA genomes using the expertise of genomics. Genetic engineering, which includes the transfection method among others, is a component of the synthetic biology that creates the new genes. The use of transfection reagents and equipment is expanding along with the need for synthetic biology products on a global scale.

Due to the rising demand for efficient and cutting-edge products, there is an increase in the market for synthetic biology products. Since gene transfer can be accompanied by a variety of methods, including transfection, the production of synthetic goods increases the market for transfection products. This means that the growth of the worldwide transfection reagent and equipment market is driven by the creation of synthetic products.

RESTRAINING FACTOR

The High Cost of the Equipments to Restrain the Market Growth

The expansion of the global transfection reagent and equipment market growth is anticipated to be constrained by the high cost of instruments, the selective effectiveness of transfection reagent, and cell damage caused by transfection methods.

• Request a Free sample to learn more about this report

•  

TRANSFECTION REAGENTS AND EQUIPMENT MARKET REGIONAL INSIGHTS

North American Region to Lead the Market with Rising Prevalence of Target Diseases

The availability of cutting-edge technologies, rising healthcare costs, rising investments in genomics research and development, and rising advances by prominent market participants are predicted to drive transfection reagents and equipment market share in North America. Throughout the projected period, it is anticipated that the region will continue on this trajectory. This is due to the availability of reputable manufacturers and significant financing to support R&D on cancer therapies, precision medicine, and sophisticated cytological investigations. Additionally, it is anticipated that key market participants' recent innovations will accelerate transfection reagents and equipment market growth.

KEY INDUSTRY PLAYERS

Key Industry Players to Promote the Market Expansion

The strategies used by market participants in recent years, such as extensions, had a substantial impact on the market's expansion. The study includes information and specifics about the businesses and how they engage with the market. Through suitable research, technological developments, expansions, and expanding machinery and equipment, the data is acquired and published. The companies that create and offer new products, the regions in which they operate, mechanisation, innovation methods, making the most money, and using their products to significantly impact society are other factors taken into account for this market.

List of Top Transfection Reagents and Equipment Companies

• Thermo Fisher (U.S.A)
• Promega (U.S.A)
• Hoffmann-La Roche (Switzerland)
• QIAGEN (The Netherlands)
• Polyplus-transfection (France)
• Bio-Rad (U.S.A)
• Lonza (Switzerland)
• Sigma-Aldrich (U.S.A)
• MirusBio (U.S.A)
• MaxCyte (U.S.A).

REPORT COVERAGE

This report includes a thorough background analysis, a parent market evaluation, and an in-depth examination of market dynamics. Market size in the past, now, and in the future in terms of both value and volume. The report includes research on recent market developments, in-depth analysis of market shares and strategies of key competitors, as well as growing niche markets and regional market sectors.